RAP media thread., page-2594

True, but I see the real value in the COVID trials success in monitoring COVID progression. Yes, we will probably be able to identify COVID by cough recognition initially, but if I am to believe the reports about Omicron, so many more people will catch it, including the immunocompromised (is that a word?) and they will need monitoring and that is also what the AI will be able to do. ResApp have already identified disease monitoring as a major market, and this sadly might become a much needed example.